Search results for: 'payer'
- Related search terms
- Payer-Provider Connectivity Solutions North American 2023
- payers healthcare AI directories
- payer digital health
- payer provider connectivity solutions north america 2023
- payer monitoring software market
-
16 Feb 2022  |  North America  |  Market Research
US Population Health Management Growth Opportunities
Data Management and Care Coordination Challenges Necessitate Cloud-based Technologies and SaaS Business Models to Drive Transformational Growth
This research service will provide an overview of the US population health management (PHM) market. The study period is from 2021 to 2026. The report will provide a detailed analysis of the PHM market and applications, such as data & analysis, care management, and performance management. Discussions include industry challenges, drivers, and restrai...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Dec 2025  |  North America  |  Market Research
United States Clinical Laboratory Services Growth Opportunities, Forecast 2030
Fueled by Specialty Testing Expansion, Digital Workflow Innovation, and Value-Based Healthcare Demands
The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...
$4,950.00 -
14 Jun 2021  |  North America  |  Market Research
Growth Opportunities for MedTech in the Transformation of the US Healthcare Provider Ecosystem
Transformational Growth in the Care Delivery Landscape is Changing Health Systems into Systems of Health
Healthcare providers are on the verge of reinventing their role in the care delivery process due to various external factors, such as the following: • Unsustainable growth in healthcare spending driving continuous downward pressure and declining operating margins • The emergence of alternative payment models that focus on patient outcome and re...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jul 2021  |  North America  |  Market Research
US Digital Therapeutics Growth Opportunities
Transformational Growth in New Business Models After COVID-19
Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Dec 2021  |  North America  |  Market Research
US Value-based Care for Medical Technology Growth Opportunities
Advanced Technologies Enable Interoperable Solutions, At-home Care, and Improved Patient Experience
The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countr...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Apr 2023  |  North America  |  Market Outlook
Global Digital Health Outlook 2023
Staff Shortage and Workflow Efficiency Solutions Will Lead to Transformational Growth of Digital Health
Frost & Sullivan defines digital health as data application for healthcare delivery using computational and telecommunication technologies to support business process workflow, clinical workflow, and patient data management. Digital health aims to achieve better patient outcomes while improving efficiency and containing costs through provider and p...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Dec 2023  |  North America  |  Market Research
Growth Opportunities in US Digital Health Solutions as an Enabler for Value-based Care
Robust Investments and Disruptive Technological Innovation Transforming Care Delivery
According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...
$2,450.00
Special Price $1,837.50 save 25 %
-
08 Jan 2018  |  South Asia, Middle East & North Africa  |  Market Research
Opportunities in the Healthcare Market in Bahrain
Ministry of Health’s new projects and mandatory health insurance to create investment opportunities
This Industry Docket provides a brief overview of the healthcare opportunity landscape in Bahrain, its position among GCC countries, its health indicators and availability of healthcare facilities, changing scenarios of payer and providers, past and future trends in inpatients and outpatients. Infrastructure and care division across the private and...
$1,500.00
Special Price $1,125.00 save 25 %
-
30 Aug 2024  |  Global  |  Market Research
Population Health Management Sector, Global, 2024 2029
Operational and Financial Challenges are Driving Transformational Growth with the Shift toward Value-based Care
Healthcare providers worldwide struggle with operational, financial, and clinical challenges on top of workforce scarcity. Payers are challenged with rising healthcare costs and shrinking margins. Payers, providers, and policymakers seek ways to curb these expenditures. Population health management (PHM) software that enables cost containment strat...
$4,950.00
Special Price $4,207.50 save 15 %
-
11 Sep 2026  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generation of evidence to support the drug’s value proposi...
$4,950.00